IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,365 | -71.9% | 30,256 | -69.3% | 0.00% | -100.0% |
| Q1 2023 | $1,035,641 | -75.9% | 98,445 | -71.6% | 0.00% | -71.4% |
| Q4 2022 | $4,289,530 | -17.4% | 346,209 | -31.0% | 0.01% | -22.2% |
| Q3 2022 | $5,196,000 | +1673.4% | 501,577 | +1876.6% | 0.01% | – |
| Q2 2022 | $293,000 | -35.0% | 25,376 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $451,000 | -65.8% | 34,994 | -69.1% | 0.00% | -50.0% |
| Q4 2021 | $1,320,000 | -45.1% | 113,234 | -38.5% | 0.00% | -50.0% |
| Q3 2021 | $2,404,000 | +1.5% | 184,074 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $2,369,000 | +116.1% | 184,074 | +87.7% | 0.00% | +200.0% |
| Q1 2021 | $1,096,000 | -56.8% | 98,045 | -56.0% | 0.00% | -50.0% |
| Q4 2020 | $2,536,000 | +152.8% | 222,666 | +106.5% | 0.00% | 0.0% |
| Q3 2020 | $1,003,000 | – | 107,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |